# Efficacy of Dexamethasone to Improve Clinical Outcomes in Coronary Artery Bypass Patients

Study · id `cardio:ct-nct05487508` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05487508](<https://clinicaltrials.gov/study/NCT05487508>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05487508

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT05487508. Randomized; double masking; primary purpose treatment. Start 2018-07-01 (actual); primary completion 2019-01-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT05487508, source copy `cardio:ctgov-nct05487508-2022-08-04`, retrieved 2026-10-26)
- Started: 2018-07-01 (actual) (ClinicalTrials.gov record NCT05487508, source copy `cardio:ctgov-nct05487508-2022-08-04`, retrieved 2026-10-26)
- Primary completion: 2019-01-31 (actual) (ClinicalTrials.gov record NCT05487508, source copy `cardio:ctgov-nct05487508-2022-08-04`, retrieved 2026-10-26)
- Completion: 2019-03-31 (actual) (ClinicalTrials.gov record NCT05487508, source copy `cardio:ctgov-nct05487508-2022-08-04`, retrieved 2026-10-26)
- Countries: Indonesia (ClinicalTrials.gov record NCT05487508, source copy `cardio:ctgov-nct05487508-2022-08-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05487508-2022-08-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Dexamethasone to Improve Clinical Outcomes in Coronary Artery Bypass Patients
- Condition: Coronary Artery Disease
- Condition: Inflammatory Response
- Intervention (Drug): Dexamethasone
- Intervention (Drug): Normal saline
- Lead sponsor: Universitas Indonesia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Universitas Indonesia (`cardio:org-universitas-indonesia`)

## Provenance

Content hash: 4f76411d5399cb6c4d82096e4a8f8e31ea60e2dcb4b1677cf5c5fa34b7c2197f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
